Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.08
+0.10 (1.25%)
At close: Sep 15, 2025, 4:00 PM EDT
8.04
-0.04 (-0.49%)
After-hours: Sep 15, 2025, 7:51 PM EDT
Novavax Stock Forecast
Stock Price Forecast
The 7 analysts that cover Novavax stock have a consensus rating of "Buy" and an average price target of $14.29, which forecasts a 76.86% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $26.
Price Target: $14.29 (+76.86%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Novavax stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 0 | 1 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 2 | 2 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Total | 6 | 6 | 5 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +23.76% | Aug 28, 2025 |
| B of A Securities | B of A Securities | Hold → Sell Downgrades $9 → $7 | Hold → Sell | Downgrades | $9 → $7 | -13.37% | Aug 20, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +11.39% | Jul 22, 2025 |
| Citigroup | Citigroup | Strong Sell Initiates $6 | Strong Sell | Initiates | $6 | -25.74% | Jun 17, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $9 → $7 | Sell | Maintains | $9 → $7 | -13.37% | May 9, 2025 |
Financial Forecast
Revenue This Year
1.10B
from 682.16M
Increased by 61.69%
Revenue Next Year
498.16M
from 1.10B
Decreased by -54.84%
EPS This Year
2.30
from -1.23
EPS Next Year
0.22
from 2.30
Decreased by -90.46%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.3B | 1.0B | |||
| Avg | 1.1B | 498.2M | |||
| Low | 982.5M | 298.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 86.0% | -5.2% | |||
| Avg | 61.7% | -54.8% | |||
| Low | 44.0% | -72.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.13 | 3.05 | |||
| Avg | 2.30 | 0.22 | |||
| Low | 1.42 | -0.73 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 32.2% | |||
| Avg | - | -90.5% | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.